Mirna Therapeutics, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mirna Therapeutics, Inc..The latest application filed is for "combination cancer treatments utilizing synthetic oligonucleotides and egfr-tki inhibitors".

Company Profile

0.14.19

Mirna Therapeutics, Inc. - Austin TX US
Mirna Therapeutics, Inc - Austin TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Synthetic mimics of miR-124 Grant 9,611,478 - Kelnar , et al. April 4, 2	2017-04-04
Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And Egfr-tki Inhibitors App 20170035797 - BADER; Andreas ; et al.	2017-02-09
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis Grant 9,540,645 - Shen , et al. January 10, 2	2017-01-10
Sorafenib-microRNA combination therapy for liver cancer Grant 9,517,245 - Bader , et al. December 13, 2	2016-12-13
Compositions And Methods Related To Mirna Modulation Of Neovascularization Or Angiogenesis App 20160222385 - SHEN; Jikui ; et al.	2016-08-04
Synthetic mimics of miR-34 Grant 9,371,526 - Kelnar , et al. June 21, 2	2016-06-21
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis Grant 9,365,852 - Shen , et al. June 14, 2	2016-06-14
Combination Cancer Therapy With C-met Inhibitors And Synthetic Oligonucleotides App 20160151406 - BADER; Andreas ; et al.	2016-06-02
Microrna Dosing Regimens App 20160136181 - Kim; Sinil	2016-05-19
Synthetic Mimics Of Mir-124 App 20160060629 - KELNAR; Kevin ; et al.	2016-03-03
Synthetic Mimics Of Mir-34 App 20160053264 - KELNAR; Kevin ; et al.	2016-02-25
Synthetic mimics of MIR-124 Grant 9,222,085 - Kelnar , et al. December 29, 2	2015-12-29
Compositions And Methods Related To Mirna Modulation Of Neovascularization Or Angiogenesis App 20150344880 - SHEN; Jikui ; et al.	2015-12-03
Methods And Compositions Involving Mirna And Mirna Inhibitor Molecules App 20150344881 - BROWN; David ; et al.	2015-12-03
Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitors App 20150272981 - BADER; Andreas ; et al.	2015-10-01
Sorafenib-microrna Combination Therapy For Liver Cancer App 20150246070 - Bader; Andreas ; et al.	2015-09-03
Compositions for the in vivo delivery of RNAi agents Grant 8,900,627 - Ford , et al. December 2, 2	2014-12-02
Methods And Compositions Involving Mirna And Mirna Inhibitor Molecules App 20140314833 - Brown; David ; et al.	2014-10-23
Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And Egfr-tki Inhibitors App 20140308274 - Bader; Andreas ; et al.	2014-10-16
Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitors App 20140309278 - BADER; ANDREAS ; et al.	2014-10-16
Synthetic Mimics Of Mir-34 App 20140107182 - Kelnar; Kevin ; et al.	2014-04-17
Synthetic mimics of miR-34 Grant 8,586,727 - Kelnar , et al. November 19, 2	2013-11-19
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis Grant 8,258,111 - Shen , et al. September 4, 2	2012-09-04
MiR-124 regulated genes and pathways as targets for therapeutic intervention Grant 8,071,562 - Bader , et al. December 6, 2	2011-12-06
Methods and Compositions Involving miRNAs In Cancer Stem Cells App 20100179213 - Patrawala; Lubna ; et al.	2010-07-15

Company Registrations

NCAGE Code

54S51

MIRNA THERAPEUTICS INC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.